Real-world treatment and health care utilization among patients with Duchenne muscular dystrophy by race and ethnicity in a Medicaid population
Differences were seen across race and ethnicities in select clinical characteristics, DMD treatments, and health care utilization and costs in a Medicaid population.
Authors
- Janna Manjelievskaia (ORCID: https://orcid.org/0000-0002-8293-512X)
- Megan Richards (ORCID: https://orcid.org/0000-0003-0737-389X)
- V. Merla
- A.K. Talaga
- Stanley F. Nelson
- Carolyn R. Lew (ORCID: https://orcid.org/0000-0003-1115-0672)
- Nathaniel Posner
- Jose Maria Jimenez Alvir
Institutions
- University of California, Los Angeles (US)
- Pfizer (United States) (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.18553/jmcp.2025.31.2.205
- Citations
- 1
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Pfizer